Results 331 to 340 of about 5,263,232 (399)

GLRX2 polymorphism and oxidative stress levels impact urothelial bladder cancer outcomes. [PDF]

open access: yesSci Rep
Silva IM   +13 more
europepmc   +1 more source

Integrative omics approaches to uncover liquid‐based cancer‐predicting biomarkers in Lynch syndrome

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Lynch syndrome (LS) significantly increases lifetime cancer risk, necessitating innovative approaches for risk stratification. Current risk assessment methods, however, fail to integrate data from different biological systems, which may be influenced by lifestyle factors.
Minta Kärkkäinen   +9 more
wiley   +1 more source

Over one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor survey

open access: yesInternational Journal of Cancer, EarlyView.
What's New? This study quantified the cancer burden attributable to modifiable risk factors in Guangdong, the most populous and economically advanced province in southern China. By evaluating 15 modifiable risk factors, the study reveals that over one‐third of cancer cases and two‐fifths of cancer deaths in the region could potentially be prevented ...
Xiaolan Wen   +17 more
wiley   +1 more source

Incidence and temporal trends of depression and anxiety following cancer diagnosis in Japan: Insights from the LIFE study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Depression and anxiety are common but often under‐recognized among cancer patients. Using claims data from 14 municipalities in Japan, this study clarified the incidence and temporal trends of these conditions following cancer diagnosis over a 24‐month follow‐up period.
Kengo Kawaguchi   +5 more
wiley   +1 more source

Loss of METTL3 m6A methyltransferase results in short‐term progression and poor treatment outcome of bladder cancer patients

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Bladder cancer exhibits a highly heterogeneous molecular landscape and treatment response. The dysregulation of RNA modifications such as m6A has been involved in cancer initiation and progression. This study comprehensively analyzed the expression of the main catalytic component of the m6A methylation machinery in bladder tumors across one
Katerina‐Marina Pilala   +10 more
wiley   +1 more source

Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer. [PDF]

open access: yesFront Cell Dev Biol
Ruiz-Lorente I   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy